SW
DXCM icon

SVB Wealth’s DexCom DXCM Stock Holding History

SVB Wealth’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-2,975
Closed -$231K – 1563
2024
Q4 		$231K Buy
+2,975
New +$220K ﹤0.01% 635
2024
Q3 		– Sell
-3,124
Closed -$354K – 180
2024
Q2 		$354K Buy
3,124
+684
+28% +$86.5K 0.01% 512
2024
Q1 		$338K Buy
2,440
+10
+0.4% +$1.26K 0.01% 594
2023
Q4 		$302K Buy
+2,430
New +$248K 0.01% 627
2023
Q3 		– Sell
-2,260
Closed -$290K – 885
2023
Q2 		$290K Sell
2,260
-623
-22% -$75.3K 0.01% 691
2023
Q1 		$335K Sell
2,883
-618
-18% -$69.2K ﹤0.01% 677
2022
Q4 		$396K Buy
3,501
+274
+8% +$30.1K 0.01% 627
2022
Q3 		$260K Buy
+3,227
New +$273K ﹤0.01% 743
2021
Q4 		– Sell
-2,604
Closed -$356K – 854
2021
Q3 		$356K Buy
2,604
+668
+35% +$84.2K ﹤0.01% 713
2021
Q2 		$207K Buy
+1,936
New +$186K ﹤0.01% 882

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

SVB Wealth's DXCM Position: Q1 2025 in Review

SVB Wealth sold out of DexCom (DXCM) in Q1 2025, closing a stake of 2,975 shares — an estimated $231K sold.

SVB Wealth first reported a position in DXCM in Q2 2021 and held it in 10 quarters. The position peaked at $396K in Q4 2022. 932 funds tracked by Wall St. Rank hold DXCM as of Q1 2025.

  • SVB Wealth reported no remaining DexCom position as of Q1 2025 after selling out during the quarter.
  • SVB Wealth sold 2,975 DexCom shares in Q1 2025, an estimated $231K.
  • SVB Wealth first reported a position in DexCom in Q2 2021 and held it in 10 quarters.
  • SVB Wealth's DexCom position peaked at $396K in Q4 2022.
  • 932 funds tracked by Wall St. Rank held DexCom as of Q1 2025.

Based on SVB Wealth's 13F filing for Q1 2025, filed 14 May 2025.